Cjc-1295 Gmp

What is CJC-1295 GMP Research Material?

CJC-1295 GMP refers to the synthetic GHRH analog manufactured in compliance with Good Manufacturing Practice guidelines, ensuring strict batch-to-batch consistency, chemical identity verification, and ultra-low endotoxin limits for in vitro and animal laboratory research. Operating under cGMP standards guarantees that raw peptide synthesis, purification, and lyophilization meet institutional quality thresholds required for reproducible experimental data.

In biomedical research, utilizing research peptides produced within GMP-compliant environments mitigates experimental noise caused by residual synthesis reagents, TFA salts, or truncated peptide sequences. PX1 Research supplies cGMP-manufactured CJC-1295 exclusively formulated for laboratory research use only.

Molecular Architecture and Mechanism of Action

CJC-1295 is a 30-amino acid modified peptide derivative of human growth hormone-releasing hormone (GHRH 1-29). The molecule functions as a selective agonist at the growth hormone-releasing hormone receptor (GHRH-R) located on pituitary somatotropes. Upon receptor binding, CJC-1295 activates the adenylate cyclase pathway, increasing intracellular cyclic adenosine monophosphate (cAMP) and initiating the pulsatile synthesis and release of endogenous growth hormone (GH).

Preclinical investigations demonstrate that CJC-1295 preserves the physiologic feedback loop of the somatotropic axis while enhancing overall GH secretion density. The resulting release of GH directly stimulates hepatic production of downstream insulin-like growth factor 1 (IGF-1), a primary mediator of cellular proliferation, protein synthesis, and tissue repair pathways in preclinical models.

Researchers analyze two distinct structural variants of this peptide: Modified GRF 1-29 (often termed CJC-1295 without DAC) and CJC-1295 with Drug Affinity Complex (DAC). The addition of the DAC moiety allows covalent conjugation to endogenous plasma albumin in vivo via a reactive maleimide linker, extending the biological half-life from minutes to several days in animal models. You can explore our catalog of high-purity compounds across all peptides for specific research applications.

Preclinical Literature and Tissue Repair Research

The scientific literature extensively documents the role of CJC-1295 in sustaining systemic GH and IGF-1 levels. In rodent models, extended activation of the GHRH receptor via CJC-1295 administration has been shown to enhance nitrogen retention, accelerate protein translation in skeletal muscle tissue, and promote osteoblast differentiation.

In vitro assays examining extracellular matrix remodelling indicate that elevated IGF-1 concentrations secondary to GHRH agonist exposure enhance collagen synthesis in dermal fibroblasts and tenocytes. Researchers investigating tissue repair and cellular regeneration utilize CJC-1295 to evaluate its impact on wound healing acceleration, muscle fiber hypertrophy, and bone mineral density preservation under catabolic stress.

Furthermore, animal models exploring metabolic regulation demonstrate that long-acting GHRH analogs influence lipid metabolism by promoting lipolysis in visceral adipocytes while preserving lean tissue mass. For comprehensive data on secretagogues, review our dedicated resource on growth hormone secretagogues.

Quality Verification: HPLC, Mass Spectrometry, and Endotoxin Testing

To achieve reliable data in physiological and cellular assays, laboratory researchers require rigorous analytical validation of peptide reagents. Every batch of CJC-1295 produced for PX1 Research undergoes rigorous analytical testing in an ISO 17025 accredited laboratory prior to distribution.

Purity is quantified utilizing Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC). This method isolates the target 30-amino acid peptide from synthesis byproducts, truncated fragments, and protecting groups, ensuring a purity baseline of ≥99.0%. Mass identity is confirmed via Electrospray Ionization Mass Spectrometry (ESI-MS), verifying the exact molecular weight against theoretical values.

In addition to purity and identity confirmation, bioburden and bacterial endotoxin levels are evaluated using Limulus Amebocyte Lysate (LAL) testing. Maintaining endotoxin levels below 0.01 EU/mg is critical for preventing unspecific inflammatory signals in cell culture or animal research models. Researchers can review lot-specific results by requesting a Certificate of Analysis (COA) directly through our research portal.

Comparative Analysis: CJC-1295 vs. Related GHRH and GHRP Compounds

When designing somatotropic research protocols, investigators often evaluate CJC-1295 alongside other GHRH derivatives and ghrelin receptor agonists to compare receptor kinetics, half-life parameters, and hormonal secretion curves.

While CJC-1295 acts directly on the GHRH receptor, short-acting analogs such as sermorelin mimic native GHRH 1-29 without structural modifications, resulting in rapid clearance suitable for acute pulsatile signaling studies. Conversely, tesamorelin incorporates a hexenoyl moiety at the N-terminus, altering stability and demonstrating unique selectivity in visceral fat metabolic research.

In contrast to GHRH analogs, ghrelin mimetic secretagogues such as ipamorelin target the growth hormone secretagogue receptor (GHS-R1a). Co-administration studies in preclinical research frequently combine GHRH agonists like CJC-1295 No DAC with selective GHRPs to observe synergistic amplification of growth hormone release from anterior pituitary cells.

Laboratory Handling and Reconstitution Standards

CJC-1295 is supplied as a sterile, lyophilized white powder to ensure long-term chemical stability. Proper laboratory handling protocols must be maintained during reconstitution to prevent peptide shear stress, degradation, or bacterial contamination.

Reconstitution should be executed using sterile bacteriostatic water (0.9% benzyl alcohol) or sterile isotonic saline, depending on the requirements of the downstream assay. The diluent should be introduced gently along the glass wall of the vial, followed by gentle swirling. Swirling avoids mechanical aggregation; aggressive agitation or vortexing must be strictly avoided as it can disrupt secondary peptide structures.

For cell culture assays requiring solvent-free or preservative-free media, sterile phosphate-buffered saline (PBS, pH 7.4) may be utilized. Reconstituted solutions should be handled under laminar flow hoods using aseptic technique to maintain sterile conditions throughout experimental procedures.

Storage Protocols and Physical Stability

Lyophilized CJC-1295 remains stable at temperature ranges between -20°C and -80°C for extended periods, protected from light and moisture desiccation. Desiccant packs should remain inside outer storage containers to protect against ambient humidity.

Once reconstituted into aqueous solution, CJC-1295 exhibits thermal sensitivity. Aliquots should be stored at 2°C to 8°C for short-term use (typically up to 14–21 days depending on diluent choice) or rapid-frozen at -80°C for long-term storage. Repeated freeze-thaw cycles must be strictly avoided, as liquid-to-solid phase transitions promote peptide cleavage and aggregation.

PX1 Research ships all research compounds in specialized protective packaging originating from our primary logistics centers in California and Arizona, ensuring structural integrity during transit.

Institutional Sourcing and GMP Compliance

Securing reliable research peptides demands complete supply chain transparency. PX1 Research manufactures all compounds within modern, GMP-compliant facilities located in the United States, adhering strictly to institutional quality management standards.

Academic laboratories, biotechnology firms, and institutional researchers requiring bulk quantities or dedicated lot reservation can coordinate directly via our wholesale account portal. Full lot traceability, standardized manufacturing records, and third-party laboratory verification ensure that every order of CJC-1295 meets strict scientific specifications required for peer-reviewed research.